Oct 17, 2022 | Business
EC Healthcare (the “Company”, which together with its subsidiaries is referred to as the “Group”, SEHK stock code: 2138), the largest non-hospital medical group in Hong Kong*, is pleased to announce that the Group expects to achieve a record-high semi-annual sales volume from April to September 2022 (the “Reporting Period”).
The demand on medical services provided by the Group remains strong and the Group’s business demonstrate resilience and momentum backed by the Group’s diversified business. The Board expects the Group to achieve a record-high semi-annual overall sales volume of no less than HK$1.8 billion for the Reporting Period, representing a no less than 17% y-o-y increase. The Group expects to achieve a no less than 30% y-o-y increase for medical services sales volume. Sales volume of other services rose by no less than 95% y-o-y, mainly driven by the acquisition of veterinary businesses.
Mr. Eddy Tang, Chairman, Executive Director and Chief Executive Officer of EC Healthcare said, EC Healthcare is always committed to building a diversified healthcare ecosystem to maximize customers’ lifetime value. Hong Kong resident now progressively building a herd immunity barrier with a population the cumulative number of reported cases of 5th wave of COVID-19 has reached over 181 million, population completed the third vaccine dose was at approximately 80.2% as of 13 October 2022. The steady recovery in local consumer sentiment is expected to benefit the Group’s business. Looking ahead, the Group is optimistic about its business development as the Hong Kong government’s pandemic policy stance is heading towards “Normalization” and recently further relaxed quarantine arrangements for inbound travelers, further boosting the market sentiment. The Group will continue to expand its businesses through organic growth as well as mergers and acquisitions, leveraging investment in IT, brand and service to enrich the Group’s enclosed diversified ecosystem. The Group will further enhance the resilience and ability to resist economic cyclical changes and further consolidate the healthcare market.”
About EC Healthcare
EC Healthcare is Hong Kong’s largest non-hospital medical service provider*, leveraging its core businesses of preventive and precision medicine, and committed to developing medical artificial intelligence by integrating its multi-disciplinary medical services. The move, which is supported by the Group’s high-end branding and quality customer services, is aimed at offering customers safe and effective healthcare and medical services with professionalism. The Group is a constituent stock of the Hang Seng Composite Index and the MSCI Hong Kong Small Cap Index.
The Group principally engages in the provision of one-stop medical and health care services in Greater China. The Group provides a full range of services and products under its well-known brands, including those of its one-stop aesthetic medical solutions provider DR REBORN which has ranked first in Hong Kong by sales for years, a professional hair care center HAIR FOREST, primary care clinics jointly established with health management centre re:HEALTH, a vaccine centre Hong Kong Professional Vaccine HKPV, General outpatient clinic Tencent Doctorwork, the largest one-stop pain management centre in Hong Kong New York Medical Group, the comprehensive dental centres Bayley & Jackson Dental Surgeons, EC DENTAL CARE and Health and Care Dental Clinic, an advanced diagnostic and imaging centre HKAI, an oncology treatment centre reVIVE, a day procedure centre HKMED, a specialty clinic PREMIER MEDICAL CENTRE, SPECIALISTS CENTRAL and NEW MEDICAL CENTER, a paediatric centre PRIME CARE, a gynaecology specialist ZENITH MEDICAL CENTER AND PRENATAL DIAGNOSIS CENTRE, PathLab Medical Laboratories, Ophthalmology Center VIVID EYE and EC Veterinary Hospital and Imaging Center.
*According to independent research conducted by Frost and Sullivan in terms of revenue in 2020 and 2021
For further information, please contact:
iPR Ogilvy Limited
Callis Lau / Lorraine Luk / Tim Tin / Sophia Wu
Tel: (852) 2136 6952 / 2169 0467 / 3920 7654 / 3920 7645
Fax: (852) 3170 6606
Email: ech@iprogilvy.com
Topic: Press release summary
Sep 10, 2022 | Business
EC Healthcare (the “Company”, which together with its subsidiaries is referred to as the “Group”, SEHK stock code: 2138), the largest non-hospital medical group in Hong Kong*, is pleased to announce that on 7 September 2022, the Group’s Chairman, Executive Director and Chief Executive Officer Mr. Tang Chi Fai further acquired a total of 170,000 shares of the Company on the open market for approximately HK$854,800 at an average price of HK$5.0282 per share. Prior to this transaction, Mr. Tang had already increased his shareholding in the Company earlier this month on 1 September 2022, acquiring a total of 107,000 shares at an average price of $5.4905 per share. After the transaction, Mr. Tang holds an aggregate of 722,204,610 shares in the Company, increasing his equity stake from 61.27% to 61.29%.
Mr. Eddy Tang, Chairman, Executive Director and Chief Executive Officer of EC Healthcare said, “In spite of the current economic climate, we are confident that the medical market will remain resilient and that long-term public-private healthcare partnerships will continue to drive up investment in Hong Kong’s private healthcare sector. Reaping the benefits from its ongoing investments in elevating healthcare service offerings, the Group exemplified solid business recovery by delivering first-quarter sales volume of no less than HK$860 million for the financial year that concluded on March 31, 2023. Management is still nevertheless upbeat about the Group’s business success going forward. In order to continue enhancing EC Healthcare’s enclosed healthcare ecosystem, the Group will go forward with its close collaboration with the major players in the technology, telecommunications, insurance, property, and pharmaceutical industries.”
About EC Healthcare
EC Healthcare is Hong Kong’s largest non-hospital medical service provider*, leveraging its core businesses of preventive and precision medicine, and committed to developing medical artificial intelligence by integrating its multi-disciplinary medical services. The move, which is supported by the Group’s high-end branding and quality customer services, is aimed at offering customers safe and effective healthcare and medical services with professionalism.
The Group principally engages in the provision of one-stop medical and health care services in Greater China. The Group provides a full range of services and products under its well-known brands, including those of its one-stop aesthetic medical solutions provider DR REBORN which has ranked first in Hong Kong by sales for years, primary care clinics jointly established with Tencent Doctorwork, chiropractic services centre New York Spine and Physiotherapy Center NYMG, health management centre re:HEALTH, a vaccine centre Hong Kong Professional Vaccine HKPV, a comprehensive dental centre EC DENTAL CARE, a diagnostic and imaging centre HKAI, an oncology treatment centre reVIVE, a day procedure centre HKMED, a specialty clinic SPECIALISTS CENTRAL, NEW MEDICAL CENTER and Prime Medical Centres, obstetrics and gynaecology specialist ZENITH MEDICAL CENTER AND PRENATAL DIAGNOSIS CENTRE, specialists central, a paediatric center PRIME CARE, cardiology center HONG KONG INTERNATIONAL CARDIOLOGY CENTER, PathLab Medical Laboratories, a professional hair care center HAIR FOREST, Ophthalmology Center VIVID EYE and EC Veterinary Hospital and Imaging Center.
*According to independent research conducted by Frost and Sullivan in terms of revenue in 2020 and 2021
Topic: Press release summary
Sep 9, 2022 | Books, Business
SAN DIEGO – Sept. 7, 2022 – PRLog — Dummit, Buchholz & Trapp is proud to announce the elevation of four associates to partnership, effective July 1, 2022. Their appointment is part of the firm’s continuing growth strategy and the first for the San Diego office since opening in 1991.
“Our new partners reflect our firm’s commitment to excellence and an equal voice in leadership,” Managing Partner Scott D. Buchholz, Esq. remarks. “They have earned our clients’ trust and our firm’s confidence in their professional abilities. It is a privilege to refer to these individuals as fellow partners.”
Our New Partners Are:
Moira S. Brennan, Esq. (San Diego): Ms. Brennan’s practice spans healthcare law, business litigation, and employment law. Ms. Brennan has expertise in matters related to healthcare including mental health care, as well as product and general liability, in both state and federal court. Along with advocacy in litigation, Ms. Brennan also advises on policies and practices to curtail regulatory issues and curtail litigation. Ms. Brennan offers consultations and presentations on healthcare compliance, evolving healthcare laws, best nursing practices, documentation, healthcare and employment policies, hiring, discrimination and harassment training.
Pari H. Granum, Esq. (San Diego): Ms. Granum focuses her practice on defending healthcare systems, hospitals, and individual health care providers in professional liability matters. She also defends general liability claims against major retail centers and other businesses throughout California. Ms. Granum has successfully resolved claims through dispositive motions and skilled settlement negotiations. She prides herself on her writing skills and ability to foster strong client relationships to ensure superior representation.
Harmon B. Levine, Esq. (Los Angeles): Mr. Levine has devoted the vast majority of his legal career to the defense of doctors, hospitals, and other health care professionals, handling alleged medical malpractice, nursing malpractice and dependent adult / elder abuse actions, with outstanding results. He is committed to the most effective and highest quality defense of our clients. He has achieved a number of jury trial defense verdicts (including high exposure cases) in his representation of hospitals.
Nicole G. Wells, Esq. (San Diego): Ms. Wells proudly represents doctors, hospital entities, and non-profit organizations and lectures on a variety of risk reduction and regulatory compliance topics. She has successfully defended individual providers and healthcare organizations against actions spanning catastrophic birth and brain injury to complex medical issues. This broad spectrum of experience allows her to quickly identify, understand and address medical-legal issues that commonly and uncommonly arise in litigation.
Our Firm’s Services:
Dummit, Buchholz & Trapp was established in 1975 to defend and serve California’s healthcare providers and hospital industry. While this remains the firm’s focus, our successful representation of healthcare clients has naturally expanded the firm’s practice to include defense of employment law claims, casualty, personal injury, and general business litigation. Our team approach is designed to deliver big-firm results with small firm responsiveness.
Find More Information:
https://www.dbt.law/
Media Contact
Dummit, Buchholz & Trapp
Shana Cruz
shana.cruz@dbt.law
(619) 231-7738
Sep 2, 2022 | Business
EC Healthcare (the “Company”, which together with its subsidiaries is referred to as the “Group”, SEHK stock code: 2138), the largest non-hospital medical group in Hong Kong*, is pleased to announce that on 1 September 2022, the Group’s Chairman, Executive Director and Chief Executive Officer Mr. Tang Chi Fai had acquired a total 107,000 shares of the Company on the open market for approximately HK$587,000 at an average price of HK$5.4905 per share. After the transaction, Mr. Tang holds an aggregate of 722,034,610 shares in the Company, increasing his equity stake from 61.26% to 61.27%.
Mr. Eddy Tang, Chairman, Executive Director and Chief Executive Officer of EC Healthcare said, “Benefitting from the result of its continuous investment in IT, brand and service, the Group recorded a sales volume of no less than HK$860 million in the first quarter of the financial year ended 31 March 2023 (April to June 2022). This shows a good recovery in its business. EC Healthcare will continue to consolidate the healthcare market through organic growth and acquisitions and thus reinforce its leading market position. The Group believes that the medical market will remain resilient in the challenging business environment and that public-private partnerships in healthcare will keep boosting spending in the market of Hong Kong’s private healthcare sector in the long run. Looking ahead, the management remains optimistic about the Group’s business performance. The Group will also forge ahead with its deep cooperation with the key players in the technology, telecommunications, insurance, property, and pharmaceutical industries so as to keep enriching EC Healthcare’s enclosed healthcare ecosystem.”
About EC Healthcare
EC Healthcare is Hong Kong’s largest non-hospital medical service provider*, leveraging its core businesses of preventive and precision medicine, and committed to developing medical artificial intelligence by integrating its multi-disciplinary medical services. The move, which is supported by the Group’s high-end branding and quality customer services, is aimed at offering customers safe and effective healthcare and medical services with professionalism.
The Group principally engages in the provision of one-stop medical and health care services in Greater China. The Group provides a full range of services and products under its well-known brands, including those of its one-stop aesthetic medical solutions provider DR REBORN which has ranked first in Hong Kong by sales for years, primary care clinics jointly established with Tencent Doctorwork, chiropractic services centre New York Spine and Physiotherapy Center NYMG, health management centre re:HEALTH, a vaccine centre Hong Kong Professional Vaccine HKPV, a comprehensive dental centre EC DENTAL CARE, a diagnostic and imaging centre HKAI, an oncology treatment centre reVIVE, a day procedure centre HKMED, a specialty clinic SPECIALISTS CENTRAL, NEW MEDICAL CENTER and Prime Medical Centres, obstetrics and gynaecology specialist ZENITH MEDICAL CENTER AND PRENATAL DIAGNOSIS CENTRE, specialists central, a paediatric center PRIME CARE, cardiology center HONG KONG INTERNATIONAL CARDIOLOGY CENTER, PathLab Medical Laboratories, a professional hair care center HAIR FOREST, Ophthalmology Center VIVID EYE and EC Veterinary Hospital and Imaging Center.
*According to independent research conducted by Frost and Sullivan in terms of revenue in 2020 and 2021
For further information, please contact:
iPR Ogilvy Limited
Callis Lau / Lorraine Luk / Charmaine Ip
Tel: (852) 2136 6952 / 2169 0467 / 3920 7649
Fax: (852) 3170 6606
Email: ech@iprogilvy.com
Topic: Press release summary
Jul 29, 2022 | Business
Blockchain in Health Today (BHTY) open access peer reviewed journal is excited to announce the 2021 Editors Best Article Award. The award will be presented to:
Author: Dr. Hao Sen Fang Andrew, Doctor Anywhere, formerly at SingHealth Polyclinics, SingHealth, Singapore
Title: Commercially Successful Blockchain Healthcare Projects: A Scoping Review
DOI: https://doi.org/10.30953/bhty.v4.166
The esteemed Award will be presented at ConV2X 2022 Blockchain in Healthcare Today and Tomorrow event, Sept 15, in Austin, TX.
For event details see https://conv2xsymposium.com/
Past winners include:
2020
William Chien, PharmD, MBA
The Last Mile: DSCSA Solution Through Blockchain Technology: Drug Tracking, Tracing, and Verification at the Last Mile of the Pharmaceutical Supply Chain with Bruin Chain.
DOI https://doi.org/10.30953/bhty.v3.134.
2019
Kevin A. Clauson, Lipscomb University
Leveraging Blockchain Technology to Enhance Supply Chain Management in Healthcare
DOI: https://doi.org/10.30953/bhty.v1.20
Blockchain in Health Today (BHTY) is the world’s first peer-reviewed journal that amplifies and disseminates distributed ledger technology research and innovations in the healthcare, information systems, clinical computing, network technology and biomedical science fields.
As innovation moves out of academia and into real world scenarios and solutions leveraging decentralized ledgers, researchers are invited to share new insights, solutions, and results including theoretical constructs, reviews, case use, technical briefs, position papers and guidelines reports impacting the blockchain in healthcare field.
Alex Colgan, a member of the Ledger Domain team, stated, “Blockchain in Healthcare Today does incredible work at the intersection between a rapidly evolving technology and a highly regulated industry essential to everyone. We chose Blockchain in Healthcare Today because they bring together the best minds in the field, with a world-class peer review process that combines speed and rigor to deliver critical insights at breakneck speed.”
To Submit a manuscript to the journal, please visit:
https://blockchainhealthcaretoday.com/index.php/journal/about/submissions
BHTY Article Compendium 2018-2021: bit.ly/3z9YCBD
About Blockchain in Healthcare Today (BHTY)
Blockchain in Healthcare Today (BHTY) is the world’s first peer reviewed open access journal that amplifies and disseminates distributed ledger technology research and innovations in the healthcare information systems, clinical computing, network technologies and biomedical sciences. Fields of interest include utility for data integrity, privacy preservation, health information systems interoperability, permissioned security for health data, clinical support and clinical trials management, supply chain management, revenue cycle automation, cost and impact, and the integration of AI and machine learning tools in this emerging specialty field of research.
The preeminent international journal is published on a continuous basis to accelerate sharing rigorously vetted theoretical and experiential knowledge required for a global multi-disciplinary ecosystem.
Topic: Press release summary
